Articles Published in 2011

Actavis partners with QRxPharma to launch novel pain medication in U.S.

Thursday, December 22, 2011 09:46 AM
Actavis has entered into a binding letter of intent (LOI) with QRxPharma to commercialize MoxDuo IR in the United States.

More... »

WIRB Copernicus Group

ClinStar names Koenig VP

Wednesday, December 21, 2011 03:04 PM

ClinStar has named Richard Koenig vice president, operations. In his new role, Richard will be responsible for project resourcing, project financial management and the development/maintenance of key project metrics

More... »

CRF Health eCOA webinar series

Takeda to integrate two subsidiaries in California

Wednesday, December 21, 2011 01:47 PM

Takeda Pharmaceutical will integrate two wholly-owned subsidiaries, Takeda San Diego (TSD) and Takeda San Francisco (TSF) on January 1, 2012. TSD will become the surviving company and change its name to Takeda California (TCAL) the same day. Keith Wilson, current president of TSD, will become the president of the new company.

More... »

Takeda to acquire Intellikine for $190 million

Wednesday, December 21, 2011 01:31 PM

Takeda Pharmaceutical and Intellikine have entered into an agreement for Takeda America Holdings to acquire Intellikine by cash. Takeda expects that the transaction will be finalized in January 2012. Under the agreement, Takeda America Holdings will acquire Intellikine for $190 million upfront and up to $120 million in additional potential clinical development milestone payments.

More... »

IRB Services awarded full accreditation by AAHRPP

Wednesday, December 21, 2011 12:42 PM

Institutional Review Board Services (IRB Services) has been awarded full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

More... »

Gong joins Premier Research

Wednesday, December 21, 2011 12:32 PM

Premier Research Group has named Hua Gong executive director of medical diagnostics. In this role, Gong will be responsible for overseeing the in vitro diagnostics (IVD) business within the company.

More... »

Merck inks license agreement with Exelisis for P13K-Delta program

Wednesday, December 21, 2011 11:57 AM

Exelixis has granted to Merck an exclusive worldwide license to its PI3K-delta research and development program, including XL499, the company’s most advanced preclinical PI3K-delta inhibitor and other related compounds. Under the agreement, Merck will have a worldwide exclusive license and have sole responsibility to research, develop, and commercialize compounds originating from the program.

More... »

Clinigene, Pacific Biomarkers collaborate

Wednesday, December 21, 2011 11:24 AM

Clinigene International and Pacific Biomarkers have formed a collaborative agreement to address the specialty biomarker and high-end clinical trial laboratory needs of the global pharmaceutical and biotechnology industry.

More... »

Warnex to sell analytical services division

Wednesday, December 21, 2011 11:10 AM

Warnex has entered into an agreement with a private company to sell its wholly-owned analytical services division, which provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Closing of this transaction will take place upon the execution of definitive documentation, which is expected to occur on or about January 15, 2012

More... »

Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs